NEW: BRCA testing for Prostate Cancer - cfDNA EQA
15 November 2021
GenQA and EMQN are proud to announce the release of a new pilot EQA for Prostate cancer testing using cfDNA in plasma.
- This pilot EQA is applicable to laboratories testing HRR pathway genes (BRCA1 and BRCA2 testing will be mandatory).
- There is no cost to participate in this pilot EQA but participation is limited to the first 50 laboratories that sign up via the EMQN or GenQA websites.
To find out more, please see out flyer or contact us: firstname.lastname@example.org.
ALL BLOG POSTS